Operating income before deduction of amortization: onconetix.gcs-web.com (ONCO)
Onconetix, Inc. (ONCO) is expanding its market presence through partnerships with urological centers, scaling the distribution of its therapeutic systems. The EBITDA_Co trend, with a value currently at 0.00, links this growth to diversification into prostate diagnostics and hormone therapy. However, small operational volumes create a fragile cash flow, despite existing demand for men's health products.
Summary analytical data breakdowns for Onconetix (ONCO)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
- company profitability and valuation multiples indicators:
ONCO - Net Profit|Expected Net Profit Onconetix, Inc.|ONCO - Price to Earnings Ratio|Market Cap to Future Earnings Ratio onconetix.gcs-web.com|ONCO - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Onconetix|ONCO - Operating profit before deduction of amortization|Earnings per share for the last 12 months Onconetix|ONCO - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months onconetix.gcs-web.com|ONCO - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Onconetix, Inc.
Summary company analytics:ONCO - Onconetix Corporation
Selecting assets with a high margin of safety begins with analyzing a business's ability to generate real cash flow before depreciation and interest. This metric measures net operating income, allowing for an assessment of the effectiveness of the Onconetix, Inc. (ONCO) customer base restructuring and the demand for men's health products through EBITDA cash flow dynamics.
Competitors of Onconetix, Inc. (ONCO)
Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Sotera Health Company (SHC)|QDEL - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization OPKO Health OPK|CDNA: Operating profit before amortization|Maravai LifeSciences Corp - Operating profit EBITDA|Fulgent (FLGT) - Operating profit before deduction of amortization|Standard BioTools Inc. (LAB) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization cytekbio.com (CTKB)|Profit before payment of interest, taxes and amortization OraSure|Operating profit before amortization XGN (Exagen Diagnostics)|Operating profit EBITDA MDXH|LUCD - Profit before interest, taxes and amortization|Prenetics - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization IMDX (Insight Molecular Diagnostics, Inc.)|Trinity Biotech Corp - Operating profit EBITDA|Operating income before deduction of amortization ProPhase Labs Inc PRPH|AIMD (Ainos Corp) - Operating profit before deduction of amortization|Operating profit before amortization CODX|Operating profit before deduction of amortization HSCS|BMRA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CDIO|Operating income before deduction of amortization Virax Biolabs Group Limited|Profit before payment of interest, taxes and amortization Bluejay BJDX|AWH: Operating profit before amortization|Accelerate Diagnostics - Operating profit EBITDA|Centogene (CNTG) - Operating profit before deduction of amortization|ENZ (enzo.com) - Operating profit before deduction of amortization|FRES - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Genetic Technologies Ltd|Profit before interest, taxes and amortization 23andMe Inc ME|Profit before payment of interest, taxes and amortization Psychemedics (PMD)
